Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01.04. | Lonza Implements Streamlined Operating Model | ||
01.04. | Cellares' Cell Shuttle Receives FDA AMT Designation | ||
31.03. | DHL Group Acquires CRYOPDP from Cryoport | ||
31.03. | Sartorius Earns ISCC Plus Certification for Production Sites | ||
31.03. | ProBioGen Appoints Alfred Merz as CEO | ||
28.03. | Novo Nordisk Enters Exclusive License Agreement with Lexicon for LX9851 | ||
28.03. | Curium Pharma Acquires Monrol | ||
28.03. | Merck Seeks FDA Approval for Subcutaneous Pembrolizumab | ||
27.03. | National Resilience Bolsters Presence in Ohio | ||
27.03. | Linearis Opens New Lab in Quebec | ||
26.03. | Singota Solutions Opens New Facility in Balerna, Switzerland | ||
26.03. | Sanofi's Chlamydia Vaccine Candidate Granted Fast Track Designation by FDA | ||
26.03. | Theratechnologies Receives FDA Approval for EGRIFTA WR | ||
26.03. | GSK's Blujepa Approved by FDA for Treatment of uUTIs | ||
25.03. | Cytiva Expands Xcellerex X-Platform Portfolio | ||
25.03. | AstraZeneca to Invest $2.5B in New Global R&D Center in Beijing | ||
25.03. | Merck & Co. Enters License Agreement with Jiangsu Hengrui Pharmaceuticals | ||
25.03. | BioDuro Opens New Lab in Shanghai | ||
25.03. | c-Lecta Launches GMP-Grade Version of Denarase High Salt | ||
25.03. | Carbogen Amcis Granted GMP Certificate for Saint-Beauzire Facility | ||
24.03. | Likarda Receives Gates Foundation Grant to Support its Core-Shell Spherification System | ||
24.03. | OFD Life Sciences Announces Leadership Changes | ||
24.03. | J&J Ups U.S. Investment to More Than $55B | ||
24.03. | Novo Nordisk Secures Triple Agonist UBT251 in $2B Deal | ||
24.03. | Everest Medicine's IND Application for EVM14 Cleared by FDA |